Durolane is a single-injection viscosupplement developed by Bioventus LLC for use in joints affected by osteoarthritis, such as the knee and hip. The product contains stabilised hyaluronic acid produced via bacterial fermentation and is free from animal-derived components.
The viscoelastic gel is designed to supplement the natural synovial fluid in the joint, supporting lubrication and shock absorption. Durolane is intended for patients experiencing joint discomfort related to degenerative joint changes and may be used as part of a non-surgical treatment approach.
Durolane is supplied as a ready-to-use, pre-filled syringe and is intended exclusively for administration by qualified healthcare professionals under appropriate clinical conditions.
When administered intra-articularly by a qualified professional, Durolane is intended to:
- supplement synovial fluid in osteoarthritic joints
- support joint lubrication and cushioning
- contribute to improved joint mobility and function
- support symptom management associated with osteoarthritis
Areas of application include:
The duration and extent of effect may vary depending on the individual condition, severity of osteoarthritis, and clinical factors.
Each Durolane package contains:
- Hyaluronic Acid – 20 mg/ml
Stabilised, non-animal derived hyaluronic acid produced by bacterial fermentation.
- Package contents:
1 pre-filled sterile syringe containing 3.0 ml of solution.
Important Notice:
Durolane is a medical device intended for professional use only.
Administration must be performed exclusively by qualified healthcare professionals.
This product information is provided for informational purposes only and does not replace medical advice, diagnosis, or treatment.
Indications, contraindications, and suitability must be assessed by the treating physician in accordance with the official instructions for use.